Repligen Corp.
Company Snapshot
Company Overview
Repligen Corp. is a life sciences company that develops and commercializes bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The majority of the 19 manufacturing sites and assembly centers are located in the U.S., and their primary warehouse and distribution centers are located in Massachusetts and California. The company’s bioprocessing business is comprised of four main segments: filtration (including fluid management), chromatography, process analytics and proteins. The company’s filtration products offer several advantages to manufacturers of biologic drugs and are used in process development and process scale (clinical and commercial) production.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Company's Business Segments
- Product : Upstream Filtration, Downstream Filtration, Chromatography, Fluid Management, Cell Culture Supplements, Ligands, Analytics, Dialysis
- Royalty and Other Income : Royalty revenues for all periods presented relate to royalties received from a third-party systems manufacturer associated with our OPUS chromatography columns.
Applications/End User Industries
- Healthcare
- Biopharmaceutical
- Research Institutes
- Life Sciences